SurModics Valuation
| SRDX Stock | USD 38.09 0.08 0.21% |
At this time, the company appears to be undervalued. SurModics has a current Real Value of $48.97 per share. The regular price of the company is $38.09. Our model measures the value of SurModics from inspecting the company fundamentals such as Return On Equity of -0.0967, operating margin of (0.02) %, and Shares Outstanding of 14.27 M as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting SurModics' valuation include:
Price Book 4.5838 | Enterprise Value 532.9 M | Enterprise Value Ebitda 175.2842 | Price Sales 4.3103 | Forward PE 181.8182 |
Undervalued
Today
Please note that SurModics' price fluctuation is very steady at this time. Calculation of the real value of SurModics is based on 3 months time horizon. Increasing SurModics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since SurModics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of SurModics Stock. However, SurModics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 38.09 | Real 48.97 | Target 59.5 | Hype 38.07 | Naive 38.4 |
The intrinsic value of SurModics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence SurModics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of SurModics helps investors to forecast how SurModics stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of SurModics more accurately as focusing exclusively on SurModics' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use SurModics' intrinsic value based on its ongoing forecasts of SurModics' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against SurModics' closest peers.
SurModics Cash |
|
SurModics Valuation Trend
Analysing the historical paterns of SurModics' enterprise value and its market capitalization is a good way to estimate and gauge the value of SurModics over time and is usually enough for investors to make rational market timing decisions.
SurModics Revenue by Product
SurModics Total Value Analysis
SurModics is at this time forecasted to have valuation of 532.87 M with market capitalization of 543.43 M, debt of 29.55 M, and cash on hands of 22.09 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the SurModics fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
532.87 M | 543.43 M | 29.55 M | 22.09 M |
SurModics Investor Information
About 84.0% of the company shares are owned by institutional investors. The book value of SurModics was at this time reported as 8.38. The company recorded a loss per share of 0.82. SurModics had not issued any dividends in recent years. The entity had 2:1 split on the 7th of December 2000. Based on the key indicators related to SurModics' liquidity, profitability, solvency, and operating efficiency, SurModics may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.SurModics Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of SurModics suggests not a very effective usage of assets in November.SurModics Ownership Allocation
The market capitalization of SurModics is $543.43 Million. The majority of SurModics outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in SurModics to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in SurModics. Please pay attention to any change in the institutional holdings of SurModics as this could imply that something significant has changed or is about to change at the company. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.SurModics Profitability Analysis
The company reported the previous year's revenue of 126.08 M. Net Loss for the year was (11.54 M) with profit before overhead, payroll, taxes, and interest of 29 M.About SurModics Valuation
Our relative valuation model uses a comparative analysis of SurModics. We calculate exposure to SurModics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of SurModics's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 93.1 M | 49.1 M | |
| Pretax Profit Margin | (0.06) | (0.06) | |
| Operating Profit Margin | (0.04) | (0.04) | |
| Net Loss | (0.09) | (0.09) | |
| Gross Profit Margin | 0.74 | 0.78 |
SurModics Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 14.2 M | |
| Quarterly Earnings Growth Y O Y | 4.358 | |
| Forward Price Earnings | 181.8182 |
SurModics Current Valuation Indicators
Valuation refers to the process of determining the present value of SurModics and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value SurModics we look at many different elements of the entity such as SurModics's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as SurModics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use SurModics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes SurModics' worth.Additional Tools for SurModics Stock Analysis
When running SurModics' price analysis, check to measure SurModics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SurModics is operating at the current time. Most of SurModics' value examination focuses on studying past and present price action to predict the probability of SurModics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SurModics' price. Additionally, you may evaluate how the addition of SurModics to your portfolios can decrease your overall portfolio volatility.